Duker indicated that EyePoint expects to report top line data for the Phase III LUGANO trial in mid-2026 with LUCIA data to follow closely, complete enrollment in the pivotal Phase III DME program in ...

Eyepoint Pharmaceuticals (NASDAQ:EYPT) outlined late-stage clinical progress for its lead retinal candidate DURAVYU and ...

When light enters the eye through the lens, specific cells on the retina are activated. As floaters move within the vitreous body, they cast shadows on the retina, creating the odd shapes many people ...

Dr Daniel Polya, an expert from Royal Australian and New Zealand College of Ophthalmologists’, explained that it's ‘so important to see an optician when a floater first appears’. The eye expert ...

Do you see small spots or threads drifting across your vision, moving away when you try to focus on them? In most cases, it is completely harmless — but here is when you should pay attention.

A newly published study found that intravitreal injection of autologous CD34+ stem cells is well tolerated and feasible for treating loss of vision resulting from central retinal vein occlusion (CRVO) ...

At Envision Summit 2026, the “Fast and Fundus” retina panel delivered rapid-fire case discussions grounded in practical decision-making. Moderated by Maria Berrocal, MD, the session moved from ...

Investing.com -- Ocular Therapeutix (NASDAQ:OCUL) stock fell 25% Tuesday after the company reported top-line results from its Phase 3 SOL-1 superiority trial for Axpaxli in wet age-related macular ...

Axpaxli shows modest advantage over Eylea in trial Retinal specialists may value trial data more than investors, analyst says Ocular plans FDA discussions and marketing application The ...

DEAR DR. ROACH: I am a 67-year-old male with generally good vision. I have had a few floaters in my eyes over the years, but they have generally been small and have not significantly affected my ...

Dear Doctors: You recently stated in a column about eye floaters that there is no cure at this time. I got a vitrectomy for this condition, and it was life-changing for me. By no means is this ...